Why M&E Is the Real ESG Power Move in Pharma

Pharmaceutical manufacturing has a clear emissions profile. Scope 1 covers on-site energy use and process emissions. Scope 2 covers purchased electricity and heat. Scope 3 spans upstream and downstream impacts, from raw materials to logistics. The structure is known. The challenge lies in execution.